http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102872051-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcc35f152994b9dd00422a05c7e7572f |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
filingDate | 2012-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8568c44c3b643a0044036a2844cd4ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ed7b2f60646f61b214ffebb865618a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc570b07d4063c42e09dcaa0f330894c |
publicationDate | 2013-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102872051-B |
titleOfInvention | Application of gypensapogenin A to antidepressant drugs |
abstract | The invention discloses application of gypensapogenin A to antidepressant drugs. Gypensapogenin A involved in the invention can be used as an antidepressant drug. The application of gypensapogenin A to the preparation of the antidepressant drugs is firstly publicized, the skeleton type is brand-new, the antidepressant activity is unexpectedly strong and the possibility of giving any revelation by other compounds does not exist, so that prominent substantive features are provided and a remarkable progress in the prevention of depression is made at the same time. |
priorityDate | 2012-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.